期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
脓毒症心肌损伤后心脏舒缩功能的动态变化 被引量:18
1
作者 夏嘉鼎 赵凯峰 +3 位作者 唐文斌 康大伟 刘畅 苏震 《中国现代医学杂志》 CAS 2019年第6期35-38,共4页
目的探讨心脏舒张、收缩功能和心肌损伤指标对脓毒症患者动态变化和预后判断的作用。方法收集脓毒症患者70例。根据28 d的预后分为生存组和死亡组。分别于入重症医学科(ICU)第1和3天应用床旁心脏超声测量二尖瓣舒张早期充盈峰速度E峰(E... 目的探讨心脏舒张、收缩功能和心肌损伤指标对脓毒症患者动态变化和预后判断的作用。方法收集脓毒症患者70例。根据28 d的预后分为生存组和死亡组。分别于入重症医学科(ICU)第1和3天应用床旁心脏超声测量二尖瓣舒张早期充盈峰速度E峰(E)与舒张晚期充盈峰速度A峰(A)、二尖瓣环舒张早期速度(e’)的比值,将E/e’及E/A作为评估左心室舒张功能的指标;测量左心室射血分数(LVEF)作为评估左心室收缩功能的指标。监测第1和3天心肌损伤标志物肌钙蛋白(cTnI)及肌酸激酶同工酶(CK-MB)水平。通过Logistic回归方法,对可能影响脓毒症预后的危险因素进行分析。结果两组患者于入ICU第3天的E/e’高于第1天(P<0.05),LVEF低于第1天(P<0.05);死亡组第1和3天的E/e’高于生存组(P<0.05)。两组第3天的cTnI、CK-MB高于第1天(P<0.05),死亡组第3天的cTnI高于生存组(P <0.05)。Logistic回归分析显示,E/e’[■4,(95%CI:1.116,1.982),P=0.003]、cTnI[■,(95%CI:0.907,1.432),P=0.039]是影响脓毒症患者28 d预后的危险因素。结论脓毒症患者存在心肌损伤,心脏舒张及收缩功能发生了动态变化,且高死亡风险脓毒症患者心脏舒缩功能及心肌损伤明显加重。E/e’、cTnI能预测脓毒症患者的预后。 展开更多
关键词 脓毒症 心肌收缩 心肌舒张 肌钙蛋白I
下载PDF
Involvement of hydrogen sulfide in the progression of renal fibrosis 被引量:5
2
作者 Yu Wang Qi-Qi Xing +11 位作者 Jing-Ke Tu wen-bin tang Xiang-Ning Yuan Yan-Yun Xie Wei Wang Zhang-Zhe Peng Ling Huang Hui Xu Jiao Qin Xiang-Cheng Xiao Li-Jian Tao Qiong-Jing Yuan 《Chinese Medical Journal》 SCIE CAS CSCD 2019年第23期2872-2880,共9页
Objective:Renal fibrosis is the most common manifestation of chronic kidney disease(CKD).Noting that existing treatments of renal fibrosis only slow disease progression but do not cure it,there is an urgent need to id... Objective:Renal fibrosis is the most common manifestation of chronic kidney disease(CKD).Noting that existing treatments of renal fibrosis only slow disease progression but do not cure it,there is an urgent need to identify novel therapies.Hydrogen sulfide(H2S)is a newly discovered endogenous small gas signaling molecule exerting a wide range of biologic actions in our body.This review illustrates recent experimental findings on the mechanisms underlying the therapeutic effects of H2S against renal fibrosis and highlights its potential in future clinical application.Data sources:Literature was collected from PubMed until February 2019,using the search terms including"Hydrogen sulfide,""Chronic kidney disease"MRenal interstitial fibrosis,"Kidney disease,""Inflammation factor,""Oxidative stress,""Epithelialto-mesenchymal transition,""H2S donor,""Hypertensive kidney dysfunction,""Myofibroblasts,""Vascular remodeling,""transforming growth factor(TGF)-beta/Smads signaling,"and"Sulfate potassium channels."Study selection:Literature was mainly derived from English articles or articles that could be obtained with English abstracts.Article type was not limited.References were also identified from the bibliographies of identified articles and the authors5 files.Results:The experimental data confirmed that H2S is widely involved in various renal pathologies by suppressing inflammation and oxidative stress,inhibiting the activation of fibrosis-related cells and their cytokine expression,ameliorating vascular remodeling and high blood pressure,stimulating tubular cell regeneration,as well as reducing apoptosis,autophagy,and hypertrophy.Therefore,H2S represents an alternative or additional therapeutic approach for renal fibrosis.Conclusions:We postulate that H2S may delay the occurrence and progress of renal fibrosis,thus protecting renal function.Further experiments are required to explore the precise role of H2S in renal fibrosis and its application in clinical treatment. 展开更多
关键词 Hydrogen sulfide Renal interstitial fibrosis Chronic kidney disease
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部